DUBLIN--(BUSINESS WIRE)--The "Pulmonary Drug Delivery Devices/Systems Market, 2014-2025" report has been added to Research and Markets' offering.
The global pulmonary drug delivery devices/systems market is expected to reach USD 55.1 billion by 2025.
Increasing prevalence of chronic respiratory diseases is expected to boost the adoption of Pulmonary Drug Delivery Systems (PDDS). As per WHO, 235 million people suffer from asthma globally. Majority of the asthma related deaths occur in middle- to low-income countries due to lack of treatment options. This shows the potential demand for pulmonary drug delivery systems in the coming years.
Technological advancements in the field of drug delivery are expected to positively impact the pulmonary drug delivery devices market. These advancements include incorporation of agglomerated vesicle technology, MDI electronic dose counter, particle engineering, and supercritical fluid technology. Rising demand for new products, changing lifestyle, ease of use, and better facilities are factors expected to provide lucrative opportunities.
Furthermore, rise in number of public and private organizations is another major factor propelling the growth of pulmonary drug delivery devices market. For instance, organizations such as the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) are engaged in providing information in clinical and basic research on allergy, asthma, and clinical immunology. Such initiatives are in turn expected to increase the market demand for respiratory drug delivery devices in developing regions, thereby boosting overall market growth.
Companies Mentioned
- GlaxoSmithKline plc
- Philips Respironics.
- Boehringer Ingelheim GmbH
- Novartis AG
- 3M Healthcare
- GF Health Products, Inc.
- Merck & Co., Inc.
- AstraZeneca
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Pulmonary Drug Delivery Systems Market Variables, Trends & Scope
Chapter 4 Pulmonary Drug Delivery Systems Market: Product Estimates & Trend Analysis
Chapter 5 Pulmonary Drug Delivery Systems Market: Application Estimates & Trend Analysis
Chapter 6 Pulmonary Drug Delivery Systems Market: Distribution Channel Estimates & Trend Analysis
Chapter 7 Pulmonary Drug Delivery Systems Market: End Use Estimates & Trend Analysis
Chapter 8 Pulmonary Drug Delivery Systems Market: Regional Estimates & Trend Analysis, by Product, Application, Distribution Channel, and End Use
Chapter 9 Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/5xghzc/pulmonary_drug
